|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.89 AUD | -2.10% |
|
+0.89% | -28.82% |
| 07-08 | Sanofi to stop disparaging rival flu vaccine to stave off EU antitrust fine | RE |
| 07-03 | Australian shares log best week in 3 as Fed-hike bets cool; banks, miners lead | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 41.74B | - | ||||
| 67.96B | |||||
| 54.4B | |||||
| 40.63B | |||||
| 30.38B | - | ||||
| 29.37B |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
